✦ LIBER ✦

Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma || Molecular Pathogenesis of Melanoma: Established and Novel Pathways

✍ Scribed by Murphy, Michael J.

Book ID: 118147500
Publisher: Springer New York
Year: 2011
Weight: 491 KB
Category: Article
ISBN: 1607614332
DOI: 10.1007/978-1-60761-433-3_3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Diagnostic and Prognostic Biomarkers and

Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma || mRNA Biomarkers in Melanoma

✍ Murphy, Michael J. 📂 Article 📅 2011 🏛 Springer New York ⚖ 346 KB

Diagnostic and Prognostic Biomarkers and

Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma Volume 1 || Chemotherapy for Melanoma

✍ Murphy, Michael J. 📂 Article 📅 2011 🏛 Springer New York ⚖ 551 KB

Targeting KIT in melanoma: A paradigm of

Targeting KIT in melanoma: A paradigm of molecular medicine and targeted therapeutics

✍ Scott E. Woodman; Michael A. Davies 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 185 KB

[Methods in Molecular Biology] Molecular

[Methods in Molecular Biology] Molecular Diagnostics for Melanoma Volume 1102 || Advances in Adjuvant Therapy: Potential for Prognostic and Predictive Biomarkers

✍ Thurin, Magdalena; Marincola, Francesco M. 📂 Article 📅 2013 🏛 Humana Press ⚖ 196 KB

486 POSTER Combined targeting of DNA rep

486 POSTER Combined targeting of DNA repair and AKT survival pathways enhance temozolomide therapeutic activity in melanoma

✍ L. Liu; Y. Miao; A. Bulgar; B. Jacobs; M. Schluchter; E. Borden; S. Gerson 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB

[Molecular Medicine and Medicinal Chemis

[Molecular Medicine and Medicinal Chemistry] Molecular Exploitation of Apoptosis Pathways in Prostate Cancer Volume 5 || Novel Molecular Therapeutics for Targeting Castration-Resistant Prostate Cancer

✍ Kyprianou, Natasha 📂 Article 📅 2012 🏛 IMPERIAL COLLEGE PRESS 🌐 English ⚖ 296 KB

This book focuses on the functional significance of targeting apoptosis for the treatment of prostate cancer. New concepts on the challenges relating to the development of resistance by androgen-independent tumors are introduced, in terms of the contribution of anoikis and cross-talk of androgens wi